Monte Rosa Therapeutics Inc.

GLUE | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.26

+$0.13 (+1.07%)

At close: Sep 21, 2026, 4:00 PM ET

$12.43

+$0.17 (+1.39%)

Pre-market: Sep 22, 2026, 8:52 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-38.63M	-72.7M	-135.35M	-108.5M	-73.96M	-35.88M
Depreciation & Amortization	8.36M	8.12M	6.22M	3.75M	2.13M	537K
Stock-Based Compensation	18.87M	18.13M	16.67M	11.66M	5.2M	354K
Other Working Capital	11.52M	84.81M	64.81M	-1.39M	6.99M	820K
Other Non-Cash Items	-2.2M	-2.95M	-3.81M	2.76M	960K	7.68M
Deferred Income Tax	n/a	n/a	n/a	n/a	17K	n/a
Change in Working Capital	-9.19M	91.4M	72.47M	-2.13M	6.29M	4.26M
Operating Cash Flow	-22.8M	42M	-43.8M	-92.47M	-59.36M	-23.05M
Capital Expenditures	-4.7M	-3.99M	-19.04M	-12.91M	-9.73M	-3.39M
Cash Acquisitions	n/a	n/a	62K	109K	79K	n/a
Purchase of Investments	-376.68M	-230.36M	-103.15M	-384.42M	n/a	n/a
Sales Maturities Of Investments	279.54M	189.9M	210.93M	178M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-101.83M	-44.45M	88.8M	-219.22M	-9.65M	-3.39M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-641K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	98.59M	n/a	411K	-3.19M	n/a
Financial Cash Flow	30.35M	98.89M	27.49M	20.47M	377.56M	60.06M
Net Cash Flow	-94.28M	96.44M	72.49M	-291.22M	308.55M	32.45M
Free Cash Flow	-27.5M	38.01M	-62.84M	-105.38M	-69.1M	-26.44M
Adj. Free Cash Flow	-46.36M	19.88M	-79.51M	-117.04M	-74.3M	-26.8M
Maintenance CapEx	n/a	n/a	-6.22M	-3.75M	-2.13M	-537K
Growth CapEx	-4.7M	-3.99M	-12.82M	-9.17M	-7.6M	-2.85M
Owner Earnings	-22.8M	42M	-50.02M	-96.21M	-61.5M	-23.59M